Table 1:
Demographic and clinical characteristics of 60 SLE patients
| Variables | N | % |
|---|---|---|
| Age group (years) | ||
| <25 | 14 | 23.3 |
| 25–44 | 33 | 55.0 |
| 45+ | 13 | 21.7 |
| Female | 58 | 96.7 |
| BMI categories (Kg/m2) | ||
| Normal (<25) | 22 | 36.7 |
| Overweight (25–29.9) | 21 | 35.0 |
| Obese 30+ | 17 | 28.3 |
| Marital status | ||
| Single | 19 | 31.7 |
| Married | 41 | 68.3 |
| Employment | ||
| Employed | 55 | 91.7 |
| Unemployed | 5 | 8.3 |
| Educational level | ||
| No formal education (illiterate / read & write) | 7 | 11.7 |
| primary school | 23 | 38.3 |
| secondary school | 17 | 28.3 |
| college/higher education | 13 | 21.7 |
| Crowding index | ||
| <2 | 13 | 21.7 |
| (2–3) | 31 | 51.7 |
| 4+ | 16 | 26.7 |
| CNS involvement Positive | 12 | 20.0 |
| Antinuclear antibodies Positive | 40 | 87.0 |
| Anti double stranded DNA Positive | 27 | 62.8 |
| Decrease C3 C4 Positive | 14 | 36.8 |
| SLE Disease duration (years)-categories | ||
| <2 | 11 | 18.3 |
| (2–9) | 39 | 65.0 |
| 10+ | 10 | 16.7 |
| Disease activity | ||
| Mild/moderate | 25 | 41.7 |
| Severe disease | 35 | 58.3 |
| History of drugs used | ||
| Prednisolone | 48 | 80.0 |
| Hydroxychloroquine | 33 | 55.0 |
| cyclophosphamide | 19 | 31.7 |
| Azathioprine | 16 | 26.7 |
| Mycophenylate | 9 | 15.0 |
| MTX | 2 | 3.3 |
| Chloroquine | 1 | 1.7 |